Kurs
+1,03%
Kurs
+1,03%
Open
39,00
High
39,50
Low
38,80
Close
39,40
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
0,24 MNOK
Likviditet
0,24 MNOK
Rel. mcap
0,04%
Antal aktier
6 258
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-10 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-05-06 | N/A | Årsstämma |
| 2025-02-12 | 08:30 | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-30 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-30 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2024-04-29 | - | Årsstämma |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2023-05-04 | - | Årsstämma |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2022-05-18 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-16 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2020-05-14 | - | Årsstämma |
| 2020-04-24 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-21 | - | Extra Bolagsstämma 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2018-07-13 | - | Extra Bolagsstämma 2018 |
| 2018-06-13 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-06-06 | - | Årsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-04-14 09:24:39
Moss, 14 April 2023
Gentian Diagnostics ASA will host a Capital Markets Day (CMD) on 10 May 2023 at
the company's headquarter in Bjørnåsveien 5, 1596 Moss, Norway. In-person
attendance is encouraged. The presentations from the event will be broadcasted
live to participants not able to join in person.
Gentian will present its strategy for growth and long-term value creation which
is founded on delivering innovative and efficient diagnostics products. Hence,
the focus of the CMD will be to provide additional insights into Gentian's
product strategies and how the company intends to leverage scientific evidence
and partnerships with major global diagnostic companies to drive sales growth.
Speakers at the capital markets day will include:
Hilja Ibert - CEO
Njaal Kind- CFO
Aleksandra Havelka - CSO
Markus Jaquemar - CCO
Torsten Knüttel - VP R&D
Programme for the day:
12.00-12.30 CEST: Registration and light lunch
12.30-15.00 CEST: Presentations and Q&A
15.00-16.00 CEST: Site visit
Please register your attendance to the capital markets day using the following
link: https://share.hsforms.com/1U6UM-O9vRvKJrGQpE0PRaw40qka , or send an e-mail
to invest@gentian.no
IR contact:
Njaal Kind, CFO
njaal.kind@gentian.no
+47 919 06 525 (mobile)